Gadobenate dimeglumine and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Gadobenate dimeglumine and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: gadobenate dimeglumine
Brand name: Multihance
Synonyms: Gadobenate Dimeglumine
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Gadobenate dimeglumine-Lithium ER
- Gadobenate dimeglumine-Lithium Oral Solution
- Gadobenate dimeglumine-Lithium Salts
- Gadobenate dimeglumine-Lithium Syrup and Oral Solution
- Gadobenate dimeglumine-Lithobid
- Gadobenate dimeglumine-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Gadobenate Intravenous
- Lithium Controlled-Release and Extended-Release Tablets-Gadobutrol
- Lithium Controlled-Release and Extended-Release Tablets-Gadobutrol Intravenous
- Lithium Controlled-Release and Extended-Release Tablets-Gadodiamide
- Lithium Controlled-Release and Extended-Release Tablets-Gadodiamide Intravenous
- Lithium Controlled-Release and Extended-Release Tablets-Gadofosveset